(1)
Zhou, L.; Peng, L. Variations and Implications of Irisin, FGF-23, and N-MID Osteocalcin in Diabetic Osteoporosis Patients Undergoing Acarbose Plus Sitagliptin Therapy: A Prospective Cohort Analysis. J Med Biochem 2025, 45 (3), 529-538. https://doi.org/10.5937/jomb0-60451.